Caeli Nova, founded in 2018 and headquartered in the United Kingdom, offers innovative solutions in aviation safety with its patented breathing technology. Known for its slogan, "A breath of fresh air," the company has developed Cordillera, an award-winning emergency oxygen system for both commercial and military aircrafts.
Cordillera stands out by improving oxygenation in high-altitude conditions, making it a crucial safety feature in case of cabin depressurization. This system not only enhances passenger protection but also offers significant operational benefits to airlines and airframers. By enabling shorter flight paths and reducing necessary fuel reserves for ETOPS flights, Cordillera contributes to lower fuel consumption and reduced carbon emissions.
Recently, Caeli Nova secured a €7.70M Series A investment in January 2022 from investors including Latecoere, Ornament Health AG, and LG Capital, positioning itself strongly for future growth.